BTL-785F Device for Non-invasive Treatment of Wrinkles and Improvement of the Face Appearance
Trial Summary
What is the purpose of this trial?
This trial is testing a special device that treats facial wrinkles without surgery. It targets people who want to reduce their wrinkles without undergoing invasive procedures. The device works by using energy to tighten the skin and boost collagen production. These methods have been reported to be safe and effective for the non-invasive treatment of wrinkles and overall facial rejuvenation.
Do I need to stop taking my current medications for this trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking isotretinoin, you must have stopped it at least 12 months before participating.
What data supports the effectiveness of the BTL-785-7 treatment?
Research suggests that targeting the BTLA/HVEM axis, which is part of the BTL-785-7 treatment, shows promise in cancer immunotherapy. This approach has been linked to encouraging preliminary results in clinical trials, especially when combined with other therapies targeting immune checkpoints like PD-1/PD-L1.12345
What safety data exists for BTL-785-7 Treatment (also known as Bruton's tyrosine kinase inhibitors)?
Bruton's tyrosine kinase inhibitors, which may include BTL-785-7 Treatment, have been associated with some cardiac risks, such as atrial fibrillation (irregular heartbeat). In studies of similar treatments, common side effects included headache, diarrhea, and fatigue, while serious side effects like pneumonia were less common. The safety profile varies between different generations of these inhibitors, with newer versions having fewer cardiovascular issues but more blood-related and digestive side effects.678910
Eligibility Criteria
Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive treatment with the BTL-785-7 applicator over four visits, 5-10 days apart
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- BTL-785-7 Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
BTL Industries Ltd.
Lead Sponsor